Inmune Bio Inc.
INMB· Nasdaq
Released May 13, 2020, after the close
10-Q filed May 14, 2020, 44 days after period end · 0001213900-20-012056
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Revenue | — | $0.00 | $0.00 |
| Net Income | -$2.07M | -$1.90M | -$2.85M |
| EPS Diluted | -$0.19 | -$0.20 | -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inmune Bio Inc. · CIK 1711754 · Engraved from SEC EDGAR